Scheduled Autologous PRP Guided Injection in the Maxillary Bony Defects
NCT ID: NCT07108933
Last Updated: 2025-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
16 participants
INTERVENTIONAL
2023-08-15
2025-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Guided Bone Regeneration Using a Mixture of Autogenous and Xenograft Particulate Versus Patient-Specific Sticky Bone for Horizontal Anterior Maxillary Defect
NCT07113886
Evaluation of Platelet Rich Fibrin / Biphasic Calcium Phosphate Effect Versus Autogenous Bone Graft on Reconstruction of Alveolar Cleft
NCT03302429
Radiographic and Histomorphometric Assessment for Maxillary Sinus Floor Elevation and Augmentation Using A Mixture of 1:1 Autogenous Bone With Deproteinized Bovine Bone Particulate Versus Deproteinized Bovine Bone Particulate
NCT07177495
Posterior Maxillary Ridge Augmentation With Sinus Lift Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft
NCT03014388
Assessment of Bone Quality and Quantity for Three Dimensional Bone Augmentation for Maxilla Using Patient Specific Titanium Meshes Loaded With Bone Marrow Aspirate Mixed With Xenograft Versus Xenograft Mixed With Autografts Only: a Randomized Clinical Trial
NCT05400044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Injection
Scheduled injection of autologous platelet-rich plasma
Autologous platelet-rich plasma
Guided injection of PRP in bony cavities of maxilla after surgical excision of non-malignant tumors.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autologous platelet-rich plasma
Guided injection of PRP in bony cavities of maxilla after surgical excision of non-malignant tumors.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Diagnosis: Non-malignant maxillary bony defects (e.g., benign tumors or cysts).
Health: Generally healthy participants who can tolerate surgery.
Platelet Function: No platelet disorders or blood-related conditions.
Willingness: Informed consent and ability to follow the protocol.
No Use of Blood Thinners: No current use of anticoagulants like aspirin.
Exclusion Criteria
Malignant Lesions: Participants with cancer or pre-cancerous conditions.
Systemic Illness: Severe conditions (e.g., uncontrolled diabetes, autoimmune disorders).
Platelet Disorders: Low platelet count or bleeding disorders (e.g., hemophilia).
Infections: Active infections or inflammatory conditions (e.g., periodontal disease).
Pregnancy: Women who are pregnant or breastfeeding.
Recent Surgery/Trauma: Recent maxillary surgery or trauma.
Uncontrolled Medications: Use of blood thinners, NSAIDs, or immunosuppressive drugs.
Non-compliance: Unwillingness or inability to follow-up with the protocol.
Substance Abuse: Active drug or alcohol abuse.
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Horus University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman Abdel Salam Yousef
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eman Abdel Salam, Prof
Role: STUDY_DIRECTOR
Head of department of Oral Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dental clinics of Aswan University Hospital
Aswān, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRP in maxillary bone defects
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.